Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How do bisphosphonates improve bone quality?].

Yasuhiro Takeuchi1

  • 1Division of Endocrinology and Nephrology, Department of Medicine, University of Tokyo School of Medicine.

Clinical Calcium
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eldecalcitol and calcium supplementation in Chinese women with postmenopausal osteoporosis: a prospective observational cohort study.

Journal of bone and mineral metabolism·2026
Same author

Unexpected [18F]-fluciclovine hyperuptake in radiation necrosis after proton therapy: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Impact of physical and chemical parameters on spinoculation for chimeric antigen receptor T cell manufacturing using a quality-by-design approach.

Molecular therapy. Advances·2026
Same author

A carotid web with accumulation of myofibroblasts: a case report.

BMC neurology·2026
Same author

Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial.

Endocrine journal·2025
Same journal

[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]

Clinical calcium·2019
Same journal

[Sequential treatment of osteoporosis with anti-sclerostin.]

Clinical calcium·2019
Same journal

[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]

Clinical calcium·2019
Same journal

[Wnt signaling in myeloma.]

Clinical calcium·2019
Same journal

[Fate decision of hematopoietic stem cells by Wnt signaling.]

Clinical calcium·2019
Same journal

[Control of inflammatory bone destruction by targeting the Wnt signaling pathway.]

Clinical calcium·2019
See all related articles

Bisphosphonates reduce fracture risk beyond increasing bone density, suggesting they improve overall bone quality. Further research into bone architecture and mineralization is crucial for understanding these effects.

Area of Science:

  • Orthopedics and Bone Biology
  • Pharmacology

Context:

  • Osteoporosis treatment efficacy is often measured by bone mineral density (BMD) increases.
  • However, anti-fracture effects of some osteoporosis drugs exceed BMD improvements.

Purpose:

  • To investigate the mechanisms by which osteoporosis drugs, particularly bisphosphonates, reduce fracture risk.
  • To explore the contribution of bone quality beyond BMD to anti-fracture efficacy.

Summary:

  • Bisphosphonates' anti-fracture effects are only partially explained by increased bone mineral density (BMD).
  • A significant portion of bisphosphonates' anti-fracture efficacy appears independent of BMD changes.
  • This suggests bisphosphonates enhance bone quality, including architecture, matrix composition, and mineralization.

Related Experiment Videos

Impact:

  • Highlights the importance of bone quality in osteoporosis management.
  • Suggests novel therapeutic targets and evaluation methods for anti-osteoporosis drugs.
  • Emphasizes the need for advanced analyses like micro computed tomography for bone biopsy specimens.